In a new National Institutes of Health-funded research report, scientists at Johns Hopkins Medicine say they have identified a potential target for drugs that could dial up or down the activity of ...

XRP has continued its uphill battle amid regulatory fog and market uncertainties. However, analysts aren’t holding back with their bold predictions that three under-the-radar tokens will mirror or ...

Scientists have discovered a potential biomarker that could more accurately identify which patients with non-hypermutated cancers will respond to specialized immunotherapy drugs called immune ...